BR100 Decreased By (-0.04%)
BR30 Decreased By (-0.01%)
KSE100 Decreased By (-0.07%)
KSE30 Decreased By (-0.15%)
AGHA 7.81 No Change ▼ 0.00 (0%)
BECO 5.17 Decreased By ▼ -0.04 (-0.77%)
BML 57.50 No Change ▼ 0.00 (0%)
BOP 33.95 Decreased By ▼ -0.08 (-0.24%)
CNERGY 10.02 Increased By ▲ 0.06 (0.6%)
CSIL 5.40 Increased By ▲ 0.09 (1.69%)
FCCL 54.60 Decreased By ▼ -0.10 (-0.18%)
FFL 16.60 Decreased By ▼ -0.09 (-0.54%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 7.40 No Change ▼ 0.00 (0%)
KOSM 5.75 Decreased By ▼ -0.02 (-0.35%)
LOTCHEM 29.20 Decreased By ▼ -0.12 (-0.41%)
MLCF 93.48 Decreased By ▼ -0.88 (-0.93%)
NBP 202.70 Decreased By ▼ -0.35 (-0.17%)
NCPL 56.99 Decreased By ▼ -0.01 (-0.02%)
NPL 67.79 Increased By ▲ 0.09 (0.13%)
OGDC 316.50 Increased By ▲ 0.66 (0.21%)
PACE 10.68 Increased By ▲ 0.04 (0.38%)
PAEL 43.36 Increased By ▲ 0.16 (0.37%)
PIBTL 16.75 Increased By ▲ 0.01 (0.06%)
PPL 219.00 Decreased By ▼ -0.78 (-0.35%)
PRL 50.00 Increased By ▲ 0.81 (1.65%)
PTC 71.02 Increased By ▲ 0.49 (0.69%)
SSGC 28.10 Decreased By ▼ -0.15 (-0.53%)
TBL 9.80 Decreased By ▼ -0.06 (-0.61%)
TELE 8.75 Decreased By ▼ -0.04 (-0.46%)
TPL 18.20 Decreased By ▼ -0.04 (-0.22%)
TPLP 13.55 Increased By ▲ 0.28 (2.11%)
TREET 22.73 Increased By ▲ 0.01 (0.04%)
TRG 60.50 Increased By ▲ 0.36 (0.6%)
By

UK’s FTSE 100 edged higher at open on Tuesday, led by mining and healthcare stocks, while shares of Ocado jumped after the online supermarket group kept its full-year guidance unchanged.

By 0716 GMT, the blue-chip FTSE 100 added 0.1%, while the more domestically-focussed FTSE 250 midcap index rose 0.2%.

Miners of both industrial and precious metals rose 0.5% each, as most metal prices appreciated on a softer dollar.

Ocado jumped 7.3% after the online supermarket and technology group kept its financial guidance for the year as it reported a return to underlying profit in its first half.

UK’s FTSE 100 falls as weak China data hits commodity stocks

AstraZeneca rose 0.8% after the US Food and Drug Administration (FDA) said it had approved the drugmaker and partner Sanofi’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.

Darktrace jumped 20.1% after the cyber-security company said a review by auditing firm EY showed “a number of areas” where its systems, processes or controls could be improved, but added that the report will not impact its previous financial statements.

Comments

Comments are closed for this article.